The use of RT-qPCR to screen for modulators of neurodegenerative disorders.


Quantitative reverse transcription is a sensitive gene analysis technique which can be used to monitor accumulation of PCR products. PCR amplification results in an increase in target amplicon leading to increased fluorescence from a fluorescent Taqman® probe. Recent advances in the throughput of this technique has enabled its consideration as a screening and hit progression tool within early drug discovery.
Here we describe the development of a high throughput RT-qPCR assay utilising suspension lymphoblasts to enable screening of a 10 thousand compound set. The aim of this screening effort is to identify compounds that reduce messenger RNA levels potentially halting progression of a genetic neurodegenerative disease. Data is nomalised against a housekeeper to determine specificity of the compound ‘effect’. Data will be presented on the assay development, validation and screen, demonstrating the utility of RT-qPCR in a screening environment.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021